Alliance for Public Health in collaboration with the International Treatment Preparedness Coalition (ITPCru) and more than 17 partner organizations updates the third edition of the report “Hepatitis C in Eastern Europe and Central Asia: Civil Society Response to the Epidemic”.

The third edition of the report was published only 2 month ago, but the changes that have taken place during this time cannot remain unnoticed. So we invite you to get acquainted with the dynamic development of treatment access in the region:
– New national protocols of hepatitis C treatment with interferon-free regimens were endorsed in Ukraine and Moldova.
– Direct-acting antivirals were registered in Moldova, Azerbaijan and Kyrgyzstan. The newest DAAs sofosbuvir+velpatasvirandelbasvir+hrazoprevir were registered in the Baltic states.
– The cost of hepatitis C treatment in Azerbaijan can be reduced by almost 20% due to the appearance of cheaper generic drugs on the market.
– Updated information on patents and patent opposition.
To learn more interesting facts, recommendations to countries on how to scale up the access to treatment, and the best practices in advocacy, read our report.